cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.11663568
title: A multigene molecular phylogeny of <i>Eisenia</i> reveals evidence for a new species, <i>Eisenia nipponica</i> (Laminariales), from Japan

description: Recently, synonymizing <i>Eisenia</i> with <i>Ecklonia</i> was suggested based on a molecular phylogeny using the <i>rbc</i>L gene and ITS1–5.8S rDNA sequences. However, in a multigene molecular phylogeny based on mitochondrial <i>cox</i>1, <i>cox</i>3 genes and the <i>atp</i>8–16S rDNA region, as well as the plastid <i>atp</i>B, <i>psa</i>A, <i>psb</i>A and <i>rbc</i>L genes, <i>Ecklonia</i> spp. formed a monophyletic clade supported by high statistical values, and <i>Eisenia</i> spp. showed monophyly depending on analytical methods. The Japanese <i>Eisenia</i> species that used to be identified as <i>Eisenia arborea</i> (<i>E. arborea sensu</i> Arasaki) was shown to be genetically distant from <i>E. arborea</i> from the NE Pacific and <i>E. bicyclis</i> from Japan. <i>Eisenia</i> spp. were morphologically distinct in having a split meristematic zone in the mature thallus forming a dorsi-ventral blade with false branches. Therefore, we propose reinstatement of <i>Eisenia</i> as an independent genus and describe a new species, <i>Eisenia nipponica</i> (= <i>E. arborea sensu</i> Arasaki) from Japan. <i>E. nipponica</i> is distributed on the Pacific Coast of central Honshu, having a separate geographic range from <i>E. bicyclis</i>, which is distributed on the Pacific coast of eastern Honshu and the Sea of Japan coast of north-western Honshu and northern Kyushu.
DOI: 10.6084/m9.figshare.11663574.v1
title: COCI Scholix dataset of all the citation data

description: This dataset contains all the citation data (in Scholix format) included in COCI, released on the 21st of January 2020.<br>This version of the dataset contains:<br>624,183,532 citations;53,464,457 bibliographic resources.The size of the zipped archive is 16.3 GB, while the size of the unzipped CSV file is 556 GB.<br>Additional information about COCI can be retrieved in the official webpage.<br>
DOI: 10.6084/m9.figshare.11663568.v1
title: A multigene molecular phylogeny of <i>Eisenia</i> reveals evidence for a new species, <i>Eisenia nipponica</i> (Laminariales), from Japan

description: Recently, synonymizing <i>Eisenia</i> with <i>Ecklonia</i> was suggested based on a molecular phylogeny using the <i>rbc</i>L gene and ITS1–5.8S rDNA sequences. However, in a multigene molecular phylogeny based on mitochondrial <i>cox</i>1, <i>cox</i>3 genes and the <i>atp</i>8–16S rDNA region, as well as the plastid <i>atp</i>B, <i>psa</i>A, <i>psb</i>A and <i>rbc</i>L genes, <i>Ecklonia</i> spp. formed a monophyletic clade supported by high statistical values, and <i>Eisenia</i> spp. showed monophyly depending on analytical methods. The Japanese <i>Eisenia</i> species that used to be identified as <i>Eisenia arborea</i> (<i>E. arborea sensu</i> Arasaki) was shown to be genetically distant from <i>E. arborea</i> from the NE Pacific and <i>E. bicyclis</i> from Japan. <i>Eisenia</i> spp. were morphologically distinct in having a split meristematic zone in the mature thallus forming a dorsi-ventral blade with false branches. Therefore, we propose reinstatement of <i>Eisenia</i> as an independent genus and describe a new species, <i>Eisenia nipponica</i> (= <i>E. arborea sensu</i> Arasaki) from Japan. <i>E. nipponica</i> is distributed on the Pacific Coast of central Honshu, having a separate geographic range from <i>E. bicyclis</i>, which is distributed on the Pacific coast of eastern Honshu and the Sea of Japan coast of north-western Honshu and northern Kyushu.
DOI: 10.6084/m9.figshare.11663574.v2
title: COCI Scholix dataset of all the citation data

description: This dataset contains all the citation data (in Scholix format) included in COCI, released on the 23rd of March 2020.<br>This version of the dataset contains:<br>655,602,113 citations;55,622,845 bibliographic resources.The size of the zipped archive is 17.3 GB, while the size of the unzipped CSV file is 584 GB.<br>Additional information about COCI can be retrieved in the official webpage.<br>
DOI: 10.6084/m9.figshare.11663574.v3
title: COCI Scholix dataset of all the citation data

description: This dataset contains all the citation data (in Scholix format) included in COCI, released on 12 May 2020.<br>This version of the dataset contains:<br>702,772,530 citations;58,028,534 bibliographic resources.The size of the zipped archive is 18.6 GB, while the size of the unzipped CSV file is 626 GB.<br>Additional information about COCI can be retrieved in the official webpage.<br>
DOI: 10.6084/m9.figshare.11663556
title: Lateral eye width for 240 species of Andean cloud forest birds

description: We quantified eye size using two sources. For 80% of the species (N = 192) we passively captured birds using mist nets at sites located within cloud forest tracts and regenerating second growth. One observer (IJA) used calipers to measure lateral eye width to the nearest 1.1mm. We compared our field measurements to published measurements of traverse eye diameter from preserved specimens for a subset of species (N =78; Ritland 1982) and found the two metrics to be highly correlated (r = 0.92, P &lt; 0.001). Hence, our field measurements can be considered accurate measures of true eye size. For the remaining 48 species (20%) we downloaded six photos per species of individuals perched in the field. We scaled photos in ImageJ using measurements of mean bill height, the position of which is clearly identified by the nares in photos. We only selected photos of birds at eye level, with the beak and eye positioned on the same focal plane. We averaged eye size across the six photos for each species and compared photo measurements from 20 species for which we also had field data. The two methods were strongly correlated (beta = 0.97, P &lt; 0.001, R-squared= 0.96). Photo measurements were on average 3% smaller than field measurements, so we calibrated mean eye size for the 48 species by multiplying by 1.03. The attached data set follows the taxonomy of the 2019 Clements List and the global Bird Tree (Jetz et al. 2012) and includes raw measurements and residuals of eye size on body mass, trophic guild and foraging stratum as described in the Elton Traits database, and classification of foraging maneuvers based on Birds of the World species accounts as either myopic (short-sited/gleaning), hyperopic (far-sighted/aerial), or nectar (hummingbirds) . See associated publication for details on analysis of eye residuals. <br>
DOI: 10.6084/m9.figshare.11663556.v1
title: Lateral eye width for 240 species of Andean cloud forest birds

description: We quantified eye size using two sources. For 80% of the species (N = 192) we passively captured birds using mist nets at sites located within cloud forest tracts and regenerating second growth. One observer (IJA) used calipers to measure lateral eye width to the nearest 1.1mm. We compared our field measurements to published measurements of traverse eye diameter from preserved specimens for a subset of species (N =78; Ritland 1982) and found the two metrics to be highly correlated (r = 0.92, P &lt; 0.001). Hence, our field measurements can be considered accurate measures of true eye size. For the remaining 48 species (20%) we downloaded six photos per species of individuals perched in the field. We scaled photos in ImageJ using measurements of mean bill height, the position of which is clearly identified by the nares in photos. We only selected photos of birds at eye level, with the beak and eye positioned on the same focal plane. We averaged eye size across the six photos for each species and compared photo measurements from 20 species for which we also had field data. The two methods were strongly correlated (beta = 0.97, P &lt; 0.001, R-squared= 0.96). Photo measurements were on average 3% smaller than field measurements, so we calibrated mean eye size for the 48 species by multiplying by 1.03. The attached data set follows the taxonomy of the 2019 Clements List and the global Bird Tree (Jetz et al. 2012) and included raw measurements and residuals of eye size on body mass. See associated publication for details on analysis of eye residuals. <br>
DOI: 10.6084/m9.figshare.11663547
title: Comparing the diversity of the casein genes in the Asian mouflon and domestic sheep - Casein SNPs

description: A total of 774 SNPs identified mapping to the casein cluster of 40 domestic sheep (Ovis aries) and 17 mouflon (Ovis orientalis)
DOI: 10.6084/m9.figshare.11663547.v1
title: Comparing the diversity of the casein genes in the Asian mouflon and domestic sheep - Casein SNPs

description: A total of 774 SNPs identified mapping to the casein cluster of 40 domestic sheep (Ovis aries) and 17 mouflon (Ovis orientalis)
DOI: 10.22023/mdx.11663544
title: Social vs. Business

description: <pre><pre>Using a combination of thematic analysis and machine learning techniques, this dataset represents a platform-specific dictionary for Airbnb guests' reviews. Lexicon is mapped into a 3-tier hierarchical structure consisting of two level 1 categories (that is, ‘business’ and ‘social’), four level 2 categories (that is, ‘property’, ‘location’, ‘professional conduct’, and ‘social interaction’), and thirteen level 3 categories.<br></pre><pre><br></pre></pre>
DOI: 10.6084/m9.figshare.11663538
title: Banerjee_EffectsKinesiologyTapingMicrocirculation_PLOSONE

description: Effects of kinesiology taping on the flow of blood in the microcirculation
DOI: 10.22023/mdx.11663544.v1
title: Social vs. Business

description: <pre><pre>Using a combination of thematic analysis and machine learning techniques, this dataset represents a platform-specific dictionary for Airbnb guests' reviews. Lexicon is mapped into a 3-tier hierarchical structure consisting of two level 1 categories (that is, ‘business’ and ‘social’), four level 2 categories (that is, ‘property’, ‘location’, ‘professional conduct’, and ‘social interaction’), and thirteen level 3 categories.<br></pre><pre><br></pre></pre>
DOI: 10.6084/m9.figshare.11663523
title: Predicted secondary metabolite biosynthetic gene clusters in 30 streptomycetes genome

description: Genomic positions and putative products of predicted secondary metabolite biosynthetic gene clusters in 30 streptomycetes genome
DOI: 10.6084/m9.figshare.11663523.v1
title: Predicted secondary metabolite biosynthetic gene clusters in 30 streptomycetes genome

description: Genomic positions and putative products of predicted secondary metabolite biosynthetic gene clusters in 30 streptomycetes genome
DOI: 10.6084/m9.figshare.11663487.v1
title: Detection of Social Signals During Communication in Media Training Using Commercial Automated Emotion Recognition Systems

description: It is well recognised that non-verbal signals play an important role in communication. Observation of videos to understand non-verbal behaviour is time-consuming and limits the potential to incorporate detailed and accurate feedback of this behaviour in practical applications. The aim of the current research is to investigate which combinations of social signals are most promising for evaluating trainees’ performance in a media interview using automatic recognition technology. Non-verbal signals were captured during practice media interviews included facial expression, hand gestures, vocal analysis and ‘honest’ signals. Interviews were categorised into effective and poor communication exemplars based on communication skills ratings provided by trainers and neutral observers. Features were selected using a correlation-based feature selection method and their accuracy was assessed using an instance-based classifier. Results revealed that participants who were rated as effective communicators in the context of a media interview smiled more, showed more vocal signals associated with passion, had a relaxed posture and had constant overall movements. These findings suggest that automated technology is capable of detecting social signals that are important for effective communication in a media interview. Results have implications for the automatic evaluation of media interviews with a number of potential application areas.
DOI: 10.6084/m9.figshare.11663475
title: KZFP genomic map data

description: Chromosomal distribution of all KRAB- and C2H2 domain pairs in the human genome (GRCh37)
DOI: 10.6084/m9.figshare.11663457
title: Data.xlsx

description: <b>Analysis of</b><b> </b><b>hydraulic fracture propagation</b><b> in concrete using the SBFEM-FVM model</b>
DOI: 10.6084/m9.figshare.11663433
title: Burned Area over Northern Boreal Region for 1982-2017

description: This data set contains an annual burned area maps time series in the Northern boreal region (North America + Eurasia) for the years 1982 to 2017, generated from the 0.05º (~5 km) Long Term Data Record data time series v5.<br> North America sub-region: 72.5°N, 168.5°W; 60°N, 43.5°WEurasia sub-region: 72.5°N, 5°E; 60°N, 180°E
DOI: 10.6084/m9.figshare.11663457.v1
title: Data.xlsx

description: <b>Analysis of</b><b> </b><b>hydraulic fracture propagation</b><b> in concrete using the SBFEM-FVM model</b>
DOI: 10.6084/m9.figshare.11663418
title: Supplementary Material for: Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study)

description: <b><i>Background:</i></b> Patients with mastocytosis often suffer from a variety of symptoms caused by mast cell mediators where treatments remain difficult, showing various success rates. Omalizumab, a monoclonal anti-IgE antibody, has been postulated to have a positive impact on mastocytosis-associated symptoms such as flush, vertigo, gastrointestinal problems, or anaphylaxis. <b><i>Objective:</i></b> To investigate the efficacy and safety of omalizumab in systemic mastocytosis. <b><i>Methods:</i></b> Patients with histologically proven mastocytosis were investigated in a multicenter prospective double-blind placebo-controlled trial to receive either omalizumab or placebo, dosed according to IgE and body weight. The primary endpoint was change in the AFIRMM activity score after 6 months of treatment. Different laboratory parameters were analyzed. <b><i>Results:</i></b> Sixteen patients were analyzed: 7 to omalizumab and 9 to placebo (mean age 47.7 ± 13.8 vs. 45.4 ± 8.8 years; 66.6 vs. 85.7% were female; mean disease duration 10.0 ± 5.1 vs. 4.5 ± 2.9 years, respectively). After 6 months the median AFIRMM score decreased 50% from 52.0 to 26.0 in the omalizumab group versus 104.0–102.0 in the placebo group (<i>p</i> = 0.286); however, the difference was not significant (<i>p</i> = 0.941). Secondary endpoints, including the number of allergic reactions, changes in major complaints, wheal-and-flare reaction due to mechanical irritation (Darier’s sign), and frequency of the use of mastocytosis-specific drugs improved in the omalizumab group, but not significantly. Adverse events like urticaria, bronchospasm, and anaphylactic shock showed no significant difference between the groups. No severe adverse events occurred. FcεRI (Fc-epsilon receptor) expression on basophils decreased after receiving omalizumab versus placebo. <b><i>Conclusion:</i></b> Omalizumab was safe and showed a tendency to improve mastocytosis-related symptoms, in particular diarrhea, dizziness, flush, and anaphylactic reactions, including the AFIRMM score and secondary endpoints; however, the difference was not significant. Due to the small study size and difference at baseline between the study groups, further studies are required to confirm our findings.
DOI: 10.6084/m9.figshare.11663418.v1
title: Supplementary Material for: Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study)

description: <b><i>Background:</i></b> Patients with mastocytosis often suffer from a variety of symptoms caused by mast cell mediators where treatments remain difficult, showing various success rates. Omalizumab, a monoclonal anti-IgE antibody, has been postulated to have a positive impact on mastocytosis-associated symptoms such as flush, vertigo, gastrointestinal problems, or anaphylaxis. <b><i>Objective:</i></b> To investigate the efficacy and safety of omalizumab in systemic mastocytosis. <b><i>Methods:</i></b> Patients with histologically proven mastocytosis were investigated in a multicenter prospective double-blind placebo-controlled trial to receive either omalizumab or placebo, dosed according to IgE and body weight. The primary endpoint was change in the AFIRMM activity score after 6 months of treatment. Different laboratory parameters were analyzed. <b><i>Results:</i></b> Sixteen patients were analyzed: 7 to omalizumab and 9 to placebo (mean age 47.7 ± 13.8 vs. 45.4 ± 8.8 years; 66.6 vs. 85.7% were female; mean disease duration 10.0 ± 5.1 vs. 4.5 ± 2.9 years, respectively). After 6 months the median AFIRMM score decreased 50% from 52.0 to 26.0 in the omalizumab group versus 104.0–102.0 in the placebo group (<i>p</i> = 0.286); however, the difference was not significant (<i>p</i> = 0.941). Secondary endpoints, including the number of allergic reactions, changes in major complaints, wheal-and-flare reaction due to mechanical irritation (Darier’s sign), and frequency of the use of mastocytosis-specific drugs improved in the omalizumab group, but not significantly. Adverse events like urticaria, bronchospasm, and anaphylactic shock showed no significant difference between the groups. No severe adverse events occurred. FcεRI (Fc-epsilon receptor) expression on basophils decreased after receiving omalizumab versus placebo. <b><i>Conclusion:</i></b> Omalizumab was safe and showed a tendency to improve mastocytosis-related symptoms, in particular diarrhea, dizziness, flush, and anaphylactic reactions, including the AFIRMM score and secondary endpoints; however, the difference was not significant. Due to the small study size and difference at baseline between the study groups, further studies are required to confirm our findings.
DOI: 10.6084/m9.figshare.11663433.v1
title: Burned Area over Northern Boreal Region for 1982-2017

description: This data set contains an annual burned area maps time series in the Northern boreal region (North America + Eurasia) for the years 1982 to 2017, generated from the 0.05º (~5 km) Long Term Data Record data time series v5.<br> North America sub-region: 72.5°N, 168.5°W; 60°N, 43.5°WEurasia sub-region: 72.5°N, 5°E; 60°N, 180°E
DOI: 10.6084/m9.figshare.11663331
title: Supplemental Data - Comprehensive profiling of Small RNAs in human embryo-conditioned culture media by improved sequencing and quantitative PCR methods

description: Supplemental Table 1: Alignment matrix detailing non-coding RNA mapping frequencies (percent total reads) for each sample.<br>Supplemental Table 2: Alignment matrix detailing non-coding RNA mapping frequencies (total raw reads) for each sample.Supplemental Table 3: Normalized read counts for annotated non-coding RNA, excluding no-embryo control samples.Supplemental Table 4: Sequencing spike-in sequences, concentrations, and total input.<br>Supplemental Figure 1: Principal component analysis with control samples excluded. ECCM samples cluster by pool size with single drop pools forming a separate cluster, suggesting that our limit of detection is 3 ECCM drops.<br>Supplemental Figure 2: Spike-in sequencing metrics. The number of molecules of spike-in RNA added to a pool of 3 drops (left y-axis) compared to the measured level of spike-in sequences in reads per million (RPM; right y-axis), totaled across all samples. Per-sample measurements are available in Supplementary Table 4.<br>
DOI: 10.6084/m9.figshare.11663331.v1
title: SupTab1 - Spike-ins.xlsx

description: Supplemental Table 1: Sequencing spike-in sequences, concentrations, and total input.Supplemental Table 2: Alignment matrix detailing non-coding RNA mapping frequencies (percent total reads) for each sample.Supplemental Table 3: Alignment matrix detailing non-coding RNA mapping frequencies (total raw reads) for each sample.Supplemental Table 4: Normalized read counts for annotated non-coding RNA, excluding no-embryo control samples.Supplemental Figure 1: Spike-in sequencing metrics. The number of molecules of spike-in RNA added to a pool of 3 drops (left y-axis) compared to the measured level of spike-in sequences in reads per million (RPM; right y-axis), totaled across all samples. Per-sample measurements are available in Supplementary Table 1.Supplemental Figure 2: Principal component analysis with control samples excluded. ECCM samples cluster by pool size with single drop pools forming a separate cluster, suggesting that our limit of detection is 3 ECCM drops.
DOI: 10.6084/m9.figshare.11663340
title: Metadata record for: Nexus of grazing management with plant and soil properties in northern China grasslands

description: This dataset contains key characteristics about the data described in the Data Descriptor Nexus of grazing management with plant and soil properties in northern China grasslands. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.11663331.v3
title: Supplemental Data - Comprehensive profiling of Small RNAs in human embryo-conditioned culture media by improved sequencing and quantitative PCR methods

description: Supplemental Table 1: Alignment matrix detailing non-coding RNA mapping frequencies (percent total reads) for each sample.<br>Supplemental Table 2: Alignment matrix detailing non-coding RNA mapping frequencies (total raw reads) for each sample.Supplemental Table 3: Normalized read counts for annotated non-coding RNA, excluding no-embryo control samples.Supplemental Table 4: Sequencing spike-in sequences, concentrations, and total input.<br>Supplemental Figure 1: Principal component analysis with control samples excluded. ECCM samples cluster by pool size with single drop pools forming a separate cluster, suggesting that our limit of detection is 3 ECCM drops.<br>Supplemental Figure 2: Spike-in sequencing metrics. The number of molecules of spike-in RNA added to a pool of 3 drops (left y-axis) compared to the measured level of spike-in sequences in reads per million (RPM; right y-axis), totaled across all samples. Per-sample measurements are available in Supplementary Table 4.<br>
DOI: 10.6084/m9.figshare.11663340.v2
title: Metadata record for: Nexus of grazing management with plant and soil properties in northern China grasslands

description: This dataset contains key characteristics about the data described in the Data Descriptor Nexus of grazing management with plant and soil properties in northern China grasslands. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>